Seafood NIC
Home
Coming Events
Consumer Seafood Information
Employment Opportunities
Guidelines and Regulations
Links and Information Sources
Marketing/Product Development
Nutrition and Food Labeling
On-Line News and Listservs
Publications
Sanitation
Seafood HACCP
Seafood HACCP Alliance
Seafood HACCP Compendium

Chapter 12: Clostridium botulinum

Updated: 12/22/2009


Potential Food Safety Hazard Contents

The following information on Clostridium botulinum is from Solomon and Lilly (1998).

C. botulinum is an anaerobic, rod-shaped sporeformer that produces a protein with characteristic neurotoxicity. Botulism, a severe food poisoning, results from ingestion of food containing botulinal toxin produced during the growth of these organisms in food. Although this food poisoning is rare, the mortality rate is high; the 962 recorded botulism outbreaks in the United States from 1899 to 1990 (CDC, 1979) involved 2320 cases and 1036 deaths. In outbreaks in which the toxin type was determined, 384 were caused by type A, 106 by type B, 105 by type E, and 3 by type F.

In two outbreaks, the foods implicated contained both types A and B toxins. The limited number of reports of C and D toxins as the causative agent of human botulism have not been generally accepted. However, all types except F and G, which have not been as thoroughly studied, are important causes of animal botulism.

Antigenic types of C. botulinum are identified by complete neutralization of their toxins by the homologous antitoxin; cross-neutralization by heterologous antitoxins does not occur or is minimal. There are seven recognized antigenic types: A, B, C, D, E, F, and G. Cultures of five of these types apparently produce only one type of toxin but all are given type designations corresponding to their toxin production. Types C and D cross-react with antitoxins to each other because they each produce more than one toxin and have at least one common toxin component. Type C produces predominantly C1 toxin with lesser amounts of D and C2, or only C2, and type D produces predominantly type D toxin along with smaller amounts of C1 and C2. Mixed toxin production by a single strain of C. botulinum may be more common than previously realized. There is a slight reciprocal cross-neutralization with types E and F, and recently a strain of C. botulinum was shown to produce a mixture of predominantly type A toxin, with a small amount of type F.

Aside from toxin type, C. botulinum can be differentiated into general groups on the basis of cultural, biochemical, and physiological characteristics. Cultures producing types C and D toxins are not proteolytic on coagulated egg white or meat and have a common metabolic pattern which sets them apart from the others. All cultures that produce type A toxin and some that produce B and F toxins are proteolytic. All type E strains and the remaining B and F strains are nonproteolytic, with carbohydrate metabolic patterns differing from the C and D nonproteolytic groups. Strains that produce type G toxin have not been studied in sufficient detail for effective and satisfactory characterization.

C. botulinum is widely distributed in soils and in sediments of oceans and lakes. The finding of type E in aquatic environments by many investigators correlates with cases of type E botulism that were traced to contaminated fish or other seafoods. Types A and B are most commonly encountered in foods subjected to soil contamination. In the United States, home-canned vegetables are most commonly contaminated with types A and B, but in Europe, meat products have also been important vehicles of food-borne illness caused by these types.

Optimum temperature for growth and toxin production of proteolytic strains is close to 35ºC; for nonproteolytic strains, it is 26-28ºC. Nonproteolytic types B, E, and F can produce toxin at refrigeration temperatures (3-4ºC). Toxins of the nonproteolytics do not manifest maximum potential toxicity until they are activated with trypsin; toxins of the proteolytics generally occur in fully (or close to fully) activated form. These and other differences can be important in epidemiological and laboratory considerations of botulism outbreaks. Clinical diagnosis of botulism is most effectively confirmed by identifying botulinal toxin in the blood, feces, or vomitus of the patient. Specimens must be collected before botulinal antitoxin is administered to the patient. Identifying the causative food is most important in preventing additional cases of botulism. See Examination of Canned Foods, Chapter 5.

Botulism in infants 6 weeks to 1 year of age was first recognized as a distinct clinical entity in 1976. This form of botulism results from growth and toxin production by C. botulinum within the intestinal tract of infants rather than from ingestion of preformed toxin. It is usually caused by C. botulinum types A or B, but a few cases have been caused by other types. Infant botulism has been diagnosed in most U.S. states and in every populated continent except Africa (Arnon, 1987).

Constipation almost always occurs in infant botulism and usually precedes characteristic signs of neuromuscular paralysis by a few days or weeks. There is a broad range of severity of illness. Some infants show only mild weakness, lethargy, and reduced feeding and do not require hospitalization. Many have shown more severe symptoms such as weakened suck, swallowing, and cry; generalized muscle weakness; and diminished gag reflex with a pooling of oral secretions. Generalized muscle weakness and loss of head control in some infants reaches such a degree of severity that the patient appears "floppy." In some hospitalized cases, respiratory arrest has occurred, but most were successfully resuscitated, and with intense supportive care have ultimately recovered. As a result, the case-fatality rate (2%) for this form of botulism is low. Recovery usually requires at least several weeks of hospitalization (Arnon, 1987).

Honey, a known source of C. botulinum spores, has been implicated in some cases of infant botulism. In studies of honey, up to 13% of the test samples contained low numbers of C. botulinum spores (Hauschild et al., 1988). For this reason, the FDA, the Centers for Disease Control and Prevention (CDC), and the American Academy of Pediatrics recommend not feeding honey to infants under the age of 1 year.

Control Measures Contents

Measures to prevent botulism include reduction of the microbial contamination level, acidification, reduction of moisture level, and whenever possible, destruction of all botulinal spores in the food. Heat processing is the most common method of destruction. Properly processed canned foods will not contain viable C. botulinum. Home-canned foods are more often a source of botulism than are commercially canned foods, which probably reflects the commercial canners' great awareness and better control of the required heat treatment.

A food may contain viable C. botulinum and still not be capable of causing botulism. If the organisms do not grow, no toxin is produced. Although many foods satisfy the nutritional requirements for the growth of C. botulinum, not all of them provide the necessary anaerobic conditions. Both nutritional and anaerobic requirements are supplied by many canned foods and by various meat and fish products. Growth in otherwise suitable foods can be prevented if the product, naturally or by design, is acidic (of low pH), has low water activity, a high concentration of NaCl, an inhibitory concentration of NaNO2 or other preservative, or two or more of these conditions in combination. Refrigeration will not prevent growth and toxin formation by nonproteolytic strains unless the temperature is precisely controlled and kept below 3ºC. Foods processed to prevent spoilage but not usually refrigerated are the most common vehicles of botulism (Solomon and Lilly, 1998).

FDA Guidelines Contents
 FDA Guidelines for C. botulinum in fish and fishery products.

Growth Contents
Limiting conditions for C. botulinum growth.

 

Heat Resistance Contents
 Spore heat resistance of C. botulinum nonproteolytic type E.
Temp. 
D-Value 
Strain 
Medium 
Reference 
(ºC) 
(ºF) 
(min.) 
     
73.89
165
12.97 
Beluga  Crabmeat Lynt et al., 1977 
73.89
165 
10.39 
Alaska  Crabmeat  Lynt et al., 1977 
73.89
165 
6.80 
G21-5  Crabmeat  Lynt et al., 1977 
73.9 
165 
8.66 
Mixed  Surimi  Rhodehamel et al., 1991
76.67
170 
4.07 
Beluga  Crabmeat  Lynt et al., 1977 
76.67
170 
3.04 
Alaska  Crabmeat  Lynt et al., 1977 
76.67
170 
2.38 
G21-5  Crabmeat  Lynt et al., 1977 
76.7 
170 
3.49 
Mixed  Surimi  Rhodehamel et al., 1991 
79.4 
175 
2.15 
Mixed  Surimi  Rhodehamel et al., 1991 
79.44
175 
1.65 
Beluga  Crabmeat  Lynt et al., 1977 
79.44
175 
1.35 
Alaska  Crabmeat  Lynt et al., 1977 
79.44
175 
1.10 
G21-5  Crabmeat  Lynt et al., 1977 
82.2 
180 
1.22 
Mixed  Surimi  Rhodehamel et al., 1991 
82.22
180 
0.74 
Beluga  Crabmeat  Lynt et al., 1977 
82.22
180 
0.51 
Alaska  Crabmeat  Lynt et al., 1977 
82.22
180 
0.63 
G21-5  Crabmeat  Lynt et al., 1977 
82.22
180 
0.62 
25V-1  Crabmeat  Lynt et al., 1977 
82.22
180 
0.49 
25V-2  Crabmeat  Lynt et al., 1977 
85.00
185 
0.29 
Beluga  Crabmeat  Lynt et al., 1977 

Spore heat resistance of C. botulinum type B.

Temp. 
D-Value
Strain 
Medium 
Reference 
(ºC)
(ºF) 
(min.) 
     
88.9
192
12.9 
N/S 
Crabmeat 
Peterson et al., 1997 
89.5
193
11.1 
N/S 
Crabmeat 
Peterson et al., 1997 
90.0
194
9.5 
N/S 
Crabmeat 
Peterson et al., 1997 
90.6
195
8.2 
N/S 
Crabmeat 
Peterson et al., 1997 
91.1
196
7.1 
N/S 
Crabmeat 
Peterson et al., 1997 
91.7
197 
6.1 
N/S 
Crabmeat 
Peterson et al., 1997 
92.2
198 
5.3 
N/S 
Crabmeat 
Peterson et al., 1997 
92.8
199 
4.5 
N/S 
Crabmeat 
Peterson et al., 1997 
93.4
200 
3.9 
N/S 
Crabmeat 
Peterson et al., 1997 
93.9
201 
3.4 
N/S 
Crabmeat 
Peterson et al., 1997 
94.5
202 
2.9 
N/S 
Crabmeat 
Peterson et al., 1997 
 N/S = Not specified

Incidence in Fish and Fishery Products Contents

Dungeness crab

Occurrence of C. botulinum in the intestinal tract, gills, and shell of Dungeness crab (Cancer magister) crab from the Pacific Coast of the United States (Eklund and Poysky, 1967).

Area No. crab % crab positive C. botulinum type
Ketchikan, AK 21 57 E
Bellingham, WA 18 61 B, E
6 66 E
32 75 E
Gray's Harbor, WA 40 75 A, E
Columbia River 20 87 E
Eureka, CA 50 14 E
Fort Bragg, CA 43 30 A, B, E
San Francisco, CA 50 12 B, C, E

Great Britain fishing grounds

Distribution of C. botulinum type E in the marine environment of Great Britain (Cann et al., 1967).
Source Sample No. tested No. containing C. botulinum type E
Shops in Britain Vacuum packed fish 646 5
Skagerrak White fish intestines 130 0
Skagerrak Whole white fish 130 0
North Sea White fish intestines 96 0
North Sea Herring intestines 200 0
Norwegian Sea Herring intestines 22 3
Norwegian Sea Whole herring 44 24
England & Wales Shellfish 106 0

Gulf of Maine fish

Total numbers of composite fish intestine (10-1/2 intestines per sample) assayed and the number containing C. botulinum toxin (Nickerson et al., 1967).
Species
Number of composite intestine samples
Number of samples containing type E toxin
Haddock
116
6
Cod
41
1
Flounder, black back
45
4
Flounder, dab
31
11
Pollock
9
0
1Non-specific

Toxin tests on Most Probable Number (MPN) cultures of frozen intestines corresponding to samples previously found to contain type E C. botulinum (Nickerson et al., 1967).

Sample Sample number MPN Type E cells per 100g
Haddock
1
10
2
<4
3
4
4
4
5
<4
6
<4
Cod
1
<4
Black back
1
<4
2
4
3
<4
4
<4

Menhaden surimi

Seven of 565 (1.2%) test portions (250g) of menhaden surimi without added cryoprotectants contained C. botulinum type E spores (Rhodehamel et al., 1991).

Seafood cocktails

C. botulinum type E was not detected in 35 samples of commercial seafood cocktails, ranging in pH from 4.10 to 4.85 (Lerke, 1973).

Smoked eel

Two of 10 (20%) different samples of smoked eel tested positive for C. botulinum type E (Abrahamsson, 1967).

Smoked salmon

119 samples of smoked salmon in Denmark were examined for C. botulinum spores. C. botulinum type B was isolated from 2 samples (1.68%). A strong inhibitory effect of formaldehyde against C. botulinum in smoked salmon was noted (Nielsen and Pedersen, 1967).

U.S. Pacific coast fish

C. botulinum toxicity screening results from fish gills and viscera (Craig and Pilcher, 1967).

Fish
No. of samples tested
No. of samples toxic
% toxic
No. of samples typed as type E
Sockeye salmon
56
12
21.4
4
Chinook salmon
91
15
16.5
4
Silver salmon
210
21
10.0
10
Sturgeon
27
3
17.0
3
Steelhead
36
7
19.4
5, 2B
Bottom fish
113
19
16.8
13, 1A

Comparative incidence of toxic specimens in ocean-caught and river caught salmon (Craig and Pilcher, 1967).

Species/location
Samples tested
No. toxic samples
% toxic samples
Silver salmon      
Port Angeles
65
1
1.5
La Push
50
3
6.0
Westport
43
4
9.3
Columbia River
28
9
32.3
Newport-Depot Bay
34
1
2.9
Chinook salmon      
Columbia River
74
15
20.3
Westport Newport
75
5
6.7

Comparative incidence of toxic specimens in bottom fish caught near Columbia River and in a distant coastal location (Craig and Pilcher, 1967).

Location
No. tested
No. toxic
% toxic
Coos Bay 54 5 9.2
Astoria 59 14 23.7

Comparative incidence of toxic specimens in miscellaneous samples tested (Craig and Pilcher, 1967).

Sample No. tested No. toxic % toxic
Clams 8 1 12.5
Oysters 3 0 0
Smelt 2 0 0
Smoked fish 15 2 7.5

U.S. Retail fish

Occurrence of C. botulinum in random samplesa of fish and other seafoods obtained from retail markets, wholesale distributors/processors, a fish farm, and fish hatchery, between 1984-1985 (Baker et al., 1990).
Common name Origin No. pos./ No. tested % Types
Butterfish California Coast
0/5
0 NA
Cat fish, farm raised Modesto, CA
3/4
75.0 3A, 1F
Indianola, MS
1/5
20.2 1A
Halibut Pacific Coast
3/11
27.3 3A
King fish Unknown
0/5
0 NA
Ling cod Pacific Coast
1/5
20.0 1A
Mackerel Unknown
0/5
0 NA
Ocean perch Pacific Coast
2/7
28.6 2A
Pacific oyster Pacific Coast
0/5
0 NA
Prawns Unknown
0/5
0 NA
Rockfish, G.I. tract
3/10
30.0 3A
Rockfish, compositea
6/6
100.0 3A
Rockfish, retail market fillets
0/8
0 NA
Rex sole California coast
2/9
22.0 1A, 1B
King salmon gills Nimbus River, CA
2/18
11/1 2A
King salmon G.I. tract Nimbus River, CA
3/8
37.5 3A
King salmon compositeb Nimbus River, CA
3/3
100.0 3A
King salmon retail market fillet Alaska
2/14
14.3 2A, 1B
Sardines Canada
2/5
40.0 1A, 1B
Scallops East Coast
1/6
16.6 1A
Shark Unknown
0/1
0 NA
Shrimp Unknown
0/5
0 NA
Smelt Unknown
0/5
0 NA
Squid Unknown
0/5
0 NA
Trout Unknown
2/6
33.3 1A, 1B
aSample units were 70g of muscle homogenate
bComposite sample: Homogenized flesh from 4-9 fish.
NA = Not applicable.

Analytical Procedures Contents
Food sampling and preparation of sample homogenate (USFDA) Contents
Clostridium botulinum (USFDA) Contents
Other analytical procedures Contents
  • Clostridium botulinum and its toxins in foods (AOAC, 1995) 
Commercial Test Products Contents
Commercial test products for C. botulinum.

Test Kit

Analytical Technique

Approx. Total Test Time1

Supplier

Probelia PCR System

Polymerase chain reaction

30 h

BioControl Systems, Inc.
Contact: Robin Forgey
12822 SE 32nd St.
Bellevue, WA 98005
Phone: 425/603-1123
E-mail:
info@rapidmethods.com
Web:
www.rapidmethods.com

1Includes enrichment

References
Contents

Abrahamsson, K. 1967. Occurrence of type E C. botulinum in smoked eel. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Ed.), p. 73-75. Chapman and Hall Ltd., London.

AOAC. 1995. Clostridium botulinum and its toxins in foods: Microbiological method. Sec. 17.7.01, Method 977.26. In Official Methods of Analysis of AOAC International, 16th ed., P.A. Cunniff (Ed.), p. 46-48. AOAC International, Gaithersburg, MD.

Arnon, S.S. 1987. Infant botulism. In Pediatrics, 18th ed., A.M. Rudolph and J.I.E. Hoffman (Eds.), p. 490-492. Appleton & Lange, Norwalk, CT.

Baker, D.A., Genigeorgis, C., and Garcia, G. 1990. Prevalence of Clostridium botulinum in seafood and significance of multiple incubation temperatures for determination of its presence and type in fresh retail fish. J. Food Protect. 53(8):668-673.

Cann, D.C., Wilson, B.B., and Shewan, J.M. 1967. C. botulinum in the marine environment of Great Britain. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Eds.), p. 62-65. Chapman and Hall Ltd., London.

Centers for Disease Control. 1979. Botulism in the United States, 1899-1977. Handbook for epidemiologists, clinicians, and laboratory workers. DHEW Publ. No. (CDC) 74-8279, Washington, DC, plus additional reports by CDC at annual meetings of the Interagency Botulism Research Coordinating Committee (IBRCC).

Craig, J.M. and Pilcher, K.S. 1967. The natural distribution of C. botulinum type E in the Pacific coast areas of the United States. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Eds.), p. 56-61. Chapman and Hall Ltd., London.

Eklund, M.W. and Poysky, F. 1967. Incidence of C. botulinum type E from the Pacific Coast of the United States. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Eds.), p. 49-53. Chapman and Hall Ltd., London.

Hauschild, A.H.W. 1989. Clostridium botulinum. Ch. 4. In Foodborne Bacterial Pathogens, M.P. Doyle (Ed.), p. 111-189. Marcel Dekker, Inc., New York.

Hauschild, A.H.W., R. Hilsheimer, K.F. Weiss, and R.B. Burke. 1988. Clostridium botulinum in honey, syrups, and dry infant cereals. J. Food Prot. 51:892-894.

Lerke, P. 1973. Evaluation of potential risk of botulism from seafood cocktails. Appl. Microbiol. 25(5):807-810.

Lynt, R.K., Solomon, H.M., Lilly, T, and Kautter, D.A. 1977. Thermal death time of Clostridium botulinum Type E in meat of the blue crab. J. Food Sci. 42(4):1022-1025.

Nickerson, J.T.R., Goldblith, S.A., DiGioia, G., and Bishop, W.W. 1967. The presence of C. botulinum, type E in fish and mud taken from the Gulf of Maine. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Eds.), p. 25-33. Chapman and Hall Ltd., London.

Nielsen, S.F. and Pedersen, H.O. 1967. Studies on the occurrence and germination of C. botulinum in smoked salmon. In Botulism 1966: Proceedings of the Fifth International Symposium on Food Microbiology, M. Ingram and T.A Roberts (Eds.), p. 66-72. Chapman and Hall Ltd., London.

Peterson, M.E., Pelroy, G.A., Poysky, F.T., Paranjpye, R.N., Dong, F.M., Pigott, G.M., and Eklund, M.W. 1997. Heat-pasteurization process for inactivation of nonproteolytic types of Clostridium botulinum in picked Dungeness crabmeat. J. Food Protect. 60(8):928-934.

Rhodehamel, E.J., Solomon, H.M., Lilly, T. Jr., Kautter, D.A. and Peter, J.T. 1991. Incidence and heat resistance of Clostridium botulinum type E spores in menhaden surimi. J. Food Sci. 56(6):1562-3, 1592.

Solomon, H.M. and Lilly, T.,Jr. 1998. Clostridium botulinum. Ch. 17. In Food and Drug Administration Bacteriological Analytical Manual, 8th ed. (revision A), (CD-ROM version). R.L. Merker (Ed.). AOAC International, Gaithersburg, MD.

Sea Grant

Updated: 12/22/09

Update Log

Pamela D. Tom, SeafoodNIC Director
Background profile

Sea Grant Extension Program
Food Science & Technology Department
University of California
One Shields Avenue, Davis, CA 95616

Mailing List Search SeafoodNIC NOAA